Jobs at Drugs for Neglected Diseases initiative (DNDi) (Now Hiring) — 3 open

Senior Accounting Officer

Kinshasa, Kinshasa, Democratic Republic of the Congo · On-site

Senior

About the Department The Operations Department manages DNDi's corporate infrastructure globally across eight locations through its Business Development, Finance, Human Resources, Information Systems and Technology, Legal…

Skills: Accounting, Financial reconciliation, Business Central, Microsoft Dynamics, Audit support

Senior Regulatory Sciences Manager

Geneva, Geneva, Switzerland · Hybrid

Senior+

About the Department Research and Development Department (R&D) About the Office Location and contract This function can either be situated in Geneva, under Swiss employment contract and with a hybrid working requirement …

Skills: Regulatory strategy, Product development, Regulatory submissions, Lifecycle management, Stakeholder management

Executive Director

Geneva, Geneva, Switzerland · On-site

Senior+

About the Department Global Executive Office About the Office Geneva, Switzerland Overview The Drugs for Neglected Diseases initiative (DNDi) is seeking an Executive Director to lead the organization through its next pha…

Skills: Strategic leadership, Global public health, Drug development, Financial management, Partnership building

About Drugs for Neglected Diseases initiative (DNDi)

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Industry
Research Services
Company size
201-500 employees
Founded
2003
Headquarters
Geneva
LinkedIn followers
56,225

The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.

Offices: 15 Chemin Camille-Vidart, Geneva, 1202, CH · George Padmore Road, Nairobi, Kilimani 254, KE · Avenue Milambo 4, Commune de la Gombe, Kinshasa 0, CD · E-13 Hauz Khaz Market, Second Floor, New Delhi, New Delhi 110016, IN · 6-12-1 Nishi-Shinjuku, 3F Parkwest Bldg, Tokyo , Tokyo 160-0023, JP

neglected diseasesdrug developmentleishmaniasishuman African trypanosomiasisChagas diseasemalariafilarial diseasespaediatric HIVopen innovationnot-for-profit
View all jobs at Drugs for Neglected Diseases initiative (DNDi)